1. Introduction
Parkinson’s disease, PD, inflammation
NEURODEGENERATIVE DISEASE, INFLAMMATION, DISEASE, NEURODEGENERATIVE DISEASES, VITAMIN D DEFICIENCY
Parkinson’s disease (PD) is the second most common neurodegenerative disease. To manage motor symptoms not controlled adequately with medication, deep brain stimulation (DBS) is used. PD patients often manifest vitamin D deficiency, which may be connected with a higher risk of falls. We administered a 12-week vitamin DParkinson’s disease (PD) is one of the most common neurodegenerative diseases worldwide. It affects approximately 1–2% of people over 60 years of age, and the number grows with age. In the future, the number of patients with PD is expected to be even higher because of the aging society [Vitamin D is one of the most significant vitamins in our organism. Calcium and phosphate homeostasis are regulated by vitamin D and parathormone [In patients with PD, inflammation is often increased when compared to healthy age-matched controls [Physical activity is the healthiest and easiest way to improve the quality of daily living in PD patients. Many studies have proven that exercises such as aerobic exercise, Nordic walking, resistance/strength training, choreotherapy, or Tai Chi successfully help slow down the development of PD, but the key is regularity. Physical activity might be low-cost and additional action to support the pharmacotherapy [Therefore, vitamin DSupplementation of vitamin DThere are a small number of studies on the application of vitamin DTherefore, the aim of this study was to explore how a 12-week BMI-based vitamin D